{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T05:56:44Z","timestamp":1783835804629,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AA025723"],"award-info":[{"award-number":["R21AA025723"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL136345"],"award-info":[{"award-number":["R01HL136345"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1-TR002378"],"award-info":[{"award-number":["UL1-TR002378"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center for Advancement of Science in Space","award":["GA-2017-266"],"award-info":[{"award-number":["GA-2017-266"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Treatment-induced cardiotoxicity is a leading noncancer-related cause of acute and late onset morbidity and mortality in cancer patients on antineoplastic drugs such as melphalan\u2014increasing clinical case reports have documented that it could induce cardiotoxicity including severe arrhythmias and heart failure. As the mechanism by which melphalan impairs cardiac cells remains poorly understood, here, we aimed to use cardiomyocytes derived from human induced pluripotent stem cells (hiPSC-CMs) to investigate the cellular and molecular mechanisms of melphalan-induced cardiotoxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      hiPSC-CMs were generated and treated with clinically relevant doses of melphalan. To characterize melphalan-induced cardiotoxicity, cell viability and apoptosis were quantified at various treatment durations. Ca\n                      <jats:sup>2+<\/jats:sup>\n                      transient and contractility analyses were used to examine the alterations of hiPSC-CM function. Proteomic analysis, reactive oxygen species detection, and RNA-Sequencing were conducted to investigate underlying mechanisms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Melphalan treatment of hiPSC-CMs induced oxidative stress, caused Ca\n                      <jats:sup>2+<\/jats:sup>\n                      handling defects and dysfunctional contractility, altered global transcriptomic and proteomic profiles, and resulted in apoptosis and cell death. The antioxidant\n                      <jats:italic>N<\/jats:italic>\n                      -acetyl-\n                      <jats:sc>l<\/jats:sc>\n                      -cysteine attenuated these genomic, cellular, and functional alterations. In addition, several other signaling pathways including the p53 and transforming growth factor-\u03b2 signaling pathways were also implicated in melphalan-induced cardiotoxicity according to the proteomic and transcriptomic analyses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Melphalan induces cardiotoxicity through the oxidative stress pathway. This study provides a unique resource of the global transcriptomic and proteomic datasets for melphalan-induced cardiotoxicity and can potentially open up new clinical mechanism-based targets to prevent and treat melphalan-induced cardiotoxicity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-020-01984-1","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T06:04:00Z","timestamp":1604556240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells"],"prefix":"10.1186","volume":"11","author":[{"given":"Rui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangxu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Rampoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua T.","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Fischbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon M.","family":"Castellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haian","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anant","family":"Mandawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1748-0648","authenticated-orcid":false,"given":"Chunhui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"issue":"1","key":"1984_CR1","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002661","volume":"9","author":"MW Bloom","year":"2016","unstructured":"Bloom MW, Hamo CE, Cardinale D, Ky B, Nohria A, Baer L, et al. Cancer therapy-related cardiac dysfunction and heart failure: part 1: definitions, pathophysiology, risk factors, and imaging. Circ Heart Fail. 2016;9(1):e002661.","journal-title":"Circ Heart Fail"},{"issue":"7","key":"1984_CR2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11864-019-0658-x","volume":"20","author":"TD Ryan","year":"2019","unstructured":"Ryan TD, Nagarajan R, Godown J. Pediatric cardio-oncology: development of cancer treatment-related cardiotoxicity and the therapeutic approach to affected patients. Curr Treat Options in Oncol. 2019;20(7):56.","journal-title":"Curr Treat Options in Oncol"},{"issue":"8","key":"1984_CR3","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/ajh.25117","volume":"93","author":"SV Rajkumar","year":"2018","unstructured":"Rajkumar SV. Multiple myeloma: 2018 update on diagnosis, risk-stratification, and management. Am J Hematol. 2018;93(8):981\u20131114.","journal-title":"Am J Hematol"},{"key":"1984_CR4","volume":"12","author":"TA Lawrie","year":"2015","unstructured":"Lawrie TA, Winter-Roach BA, Heus P, Kitchener HC. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. Cochrane Database Syst Rev. 2015;12:CD004706.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"1984_CR5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1182\/blood.V97.3.631","volume":"97","author":"S Giralt","year":"2001","unstructured":"Giralt S, Thall PF, Khouri I, Wang X, Braunschweig I, Ippolitti C, et al. Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood. 2001;97(3):631\u20137.","journal-title":"Blood."},{"issue":"8","key":"1984_CR6","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.005443","volume":"10","author":"V Buza","year":"2017","unstructured":"Buza V, Rajagopalan B, Curtis AB. Cancer treatment-induced arrhythmias: focus on chemotherapy and targeted therapies. Circ Arrhythm Electrophysiol. 2017;10(8):e005443.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"1984_CR7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bmt.1703098","volume":"28","author":"DS Ritchie","year":"2001","unstructured":"Ritchie DS, Seymour JF, Roberts AW, Szer J, Grigg AP. Acute left ventricular failure following melphalan and fludarabine conditioning. Bone Marrow Transplant. 2001;28(1):101\u20133.","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"1984_CR8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/clc.20904","volume":"34","author":"V Feliz","year":"2011","unstructured":"Feliz V, Saiyad S, Ramarao SM, Khan H, Leonelli F, Guglin M. Melphalan-induced supraventricular tachycardia: incidence and risk factors. Clin Cardiol. 2011;34(6):356\u20139.","journal-title":"Clin Cardiol"},{"issue":"9","key":"1984_CR9","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/bmt.2017.148","volume":"52","author":"M Arun","year":"2017","unstructured":"Arun M, Brauneis D, Doros G, Shelton AC, Sloan JM, Quillen K, et al. The incidence of atrial fibrillation among patients with AL amyloidosis undergoing high-dose melphalan and stem cell transplantation: experience at a single institution. Bone Marrow Transplant. 2017;52(9):1349\u201351.","journal-title":"Bone Marrow Transplant"},{"key":"1984_CR10","doi-asserted-by":"crossref","first-page":"240642","DOI":"10.1155\/2014\/240642","volume":"2014","author":"M Lamberti","year":"2014","unstructured":"Lamberti M, Giovane G, Garzillo EM, Avino F, Feola A, Porto S, et al. Animal models in studies of cardiotoxicity side effects from antiblastic drugs in patients and occupational exposed workers. Biomed Res Int. 2014;2014:240642.","journal-title":"Biomed Res Int"},{"issue":"9","key":"1984_CR11","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1021\/acsbiomaterials.6b00662","volume":"3","author":"B Fine","year":"2017","unstructured":"Fine B, Vunjak-Novakovic G. Shortcomings of animal models and the rise of engineered human cardiac tissue. ACS Biomater Sci Eng. 2017;3(9):1884\u201397.","journal-title":"ACS Biomater Sci Eng"},{"issue":"9","key":"1984_CR12","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/CIRCRESAHA.119.315378","volume":"125","author":"L Pang","year":"2019","unstructured":"Pang L, Sager P, Yang X, Shi H, Sannajust F, Brock M, et al. Workshop report: FDA workshop on improving cardiotoxicity assessment with human-relevant platforms. Circ Res. 2019;125(9):855\u201367.","journal-title":"Circ Res"},{"issue":"1","key":"1984_CR13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s13287-018-0947-5","volume":"9","author":"H Abou-Saleh","year":"2018","unstructured":"Abou-Saleh H, Zouein FA, El-Yazbi A, Sanoudou D, Raynaud C, Rao C, et al. The march of pluripotent stem cells in cardiovascular regenerative medicine. Stem Cell Res Ther. 2018;9(1):201.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"1984_CR14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/cpt.722","volume":"102","author":"N Shaheen","year":"2017","unstructured":"Shaheen N, Shiti A, Gepstein L. Pluripotent stem cell-based platforms in cardiac disease modeling and drug testing. Clin Pharmacol Ther. 2017;102(2):203\u20138.","journal-title":"Clin Pharmacol Ther"},{"issue":"21","key":"1984_CR15","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1161\/CIRCULATIONAHA.118.037357","volume":"139","author":"T Kitani","year":"2019","unstructured":"Kitani T, Ong SG, Lam CK, Rhee JW, Zhang JZ, Oikonomopoulos A, et al. Human induced pluripotent stem cell model of trastuzumab-induced cardiac dysfunction in breast cancer patients. Circulation. 2019;139(21):2451\u201365.","journal-title":"Circulation."},{"issue":"3","key":"1984_CR16","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/cpt.1311","volume":"105","author":"A Tripaydonis","year":"2019","unstructured":"Tripaydonis A, Conyers R, Elliott DA. Pediatric anthracycline-induced cardiotoxicity: mechanisms, pharmacogenomics, and pluripotent stem-cell modeling. Clin Pharmacol Ther. 2019;105(3):614\u201324.","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"1984_CR17","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.stemcr.2019.03.011","volume":"12","author":"S Shafaattalab","year":"2019","unstructured":"Shafaattalab S, Lin E, Christidi E, Huang H, Nartiss Y, Garcia A, et al. Ibrutinib displays atrial-specific toxicity in human stem cell-derived cardiomyocytes. Stem Cell Rep. 2019;12(5):996\u20131006.","journal-title":"Stem Cell Rep"},{"issue":"5","key":"1984_CR18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.cels.2019.03.009","volume":"8","author":"H Wang","year":"2019","unstructured":"Wang H, Sheehan RP, Palmer AC, Everley RA, Boswell SA, Ron-Harel N, et al. Adaptation of human iPSC-derived cardiomyocytes to tyrosine kinase inhibitors reduces acute cardiotoxicity via metabolic reprogramming. Cell Syst. 2019;8(5):412\u201326 e7.","journal-title":"Cell Syst"},{"issue":"27","key":"1984_CR19","doi-asserted-by":"crossref","first-page":"E1848","DOI":"10.1073\/pnas.1200250109","volume":"109","author":"X Lian","year":"2012","unstructured":"Lian X, Hsiao C, Wilson G, Zhu K, Hazeltine LB, Azarin SM, et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci U S A. 2012;109(27):E1848\u201357.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1984_CR20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.stem.2012.09.013","volume":"12","author":"S Tohyama","year":"2013","unstructured":"Tohyama S, Hattori F, Sano M, Hishiki T, Nagahata Y, Matsuura T, et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell. 2013;12(1):127\u201337.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"1984_CR21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.stemcr.2014.06.002","volume":"3","author":"DC Nguyen","year":"2014","unstructured":"Nguyen DC, Hookway TA, Wu Q, Jha R, Preininger MK, Chen X, et al. Microscale generation of cardiospheres promotes robust enrichment of cardiomyocytes derived from human pluripotent stem cells. Stem Cell Rep. 2014;3(2):260\u20138.","journal-title":"Stem Cell Rep"},{"issue":"1","key":"1984_CR22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/toxsci\/kfz038","volume":"169","author":"A Rampoldi","year":"2019","unstructured":"Rampoldi A, Singh M, Wu Q, Duan M, Jha R, Maxwell JT, et al. Cardiac toxicity from ethanol exposure in human-induced pluripotent stem cell-derived cardiomyocytes. Toxicol Sci. 2019;169(1):280\u201392.","journal-title":"Toxicol Sci"},{"key":"1984_CR23","unstructured":"FDA. EVOMELA\u00ae (melphalan) for injection, for intravenous use: FDA website; 2017 Available from: \nhttps:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/207155s001lbl.pdf\n\n."},{"issue":"1","key":"1984_CR24","first-page":"10","volume":"8","author":"RA Sansone","year":"2011","unstructured":"Sansone RA, Sansone LA. Getting a knack for NAC: N-acetyl-cysteine. Innov Clin Neurosci. 2011;8(1):10\u20134.","journal-title":"Innov Clin Neurosci"},{"issue":"3","key":"1984_CR25","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1021\/pr501277g","volume":"14","author":"H Xiao","year":"2015","unstructured":"Xiao H, Chen W, Tang GX, Smeekens JM, Wu R. Systematic investigation of cellular response and pleiotropic effects in atorvastatin-treated liver cells by MS-based proteomics. J Proteome Res. 2015;14(3):1600\u201311.","journal-title":"J Proteome Res"},{"key":"1984_CR26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2008","unstructured":"Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2008;4:44.","journal-title":"Nat Protoc"},{"issue":"5","key":"1984_CR27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/ten.tec.2014.0283","volume":"21","author":"N Huebsch","year":"2015","unstructured":"Huebsch N, Loskill P, Mandegar MA, Marks NC, Sheehan AS, Ma Z, et al. Automated video-based analysis of contractility and calcium flux in human-induced pluripotent stem cell-derived cardiomyocytes cultured over different spatial scales. Tissue Eng Part C Methods. 2015;21(5):467\u201379.","journal-title":"Tissue Eng Part C Methods"},{"issue":"5","key":"1984_CR28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nm.4087","volume":"22","author":"PW Burridge","year":"2016","unstructured":"Burridge PW, Li YF, Matsa E, Wu H, Ong SG, Sharma A, et al. Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the prediction of breast cancer patients to doxorubicin-induced cardiotoxicity. Nat Med. 2016;22(5):547\u201356.","journal-title":"Nat Med"},{"issue":"1","key":"1984_CR29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12291-014-0446-0","volume":"30","author":"A Phaniendra","year":"2015","unstructured":"Phaniendra A, Jestadi DB, Periyasamy L. Free radicals: properties, sources, targets, and their implication in various diseases. Indian J Clin Biochem. 2015;30(1):11\u201326.","journal-title":"Indian J Clin Biochem"},{"issue":"11","key":"1984_CR30","doi-asserted-by":"crossref","first-page":"a004242","DOI":"10.1101\/cshperspect.a004242","volume":"3","author":"CJ Fearnley","year":"2011","unstructured":"Fearnley CJ, Roderick HL, Bootman MD. Calcium signaling in cardiac myocytes. Cold Spring Harb Perspect Biol. 2011;3(11):a004242.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"6","key":"1984_CR31","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1161\/01.RES.0000125626.33738.E2","volume":"94","author":"XH Wehrens","year":"2004","unstructured":"Wehrens XH, Lehnart SE, Reiken SR, Marks AR. Ca2+\/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor. Circ Res. 2004;94(6):e61\u201370.","journal-title":"Circ Res"},{"issue":"9","key":"1984_CR32","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.freeradbiomed.2010.01.038","volume":"48","author":"GM Kuster","year":"2010","unstructured":"Kuster GM, Lancel S, Zhang J, Communal C, Trucillo MP, Lim CC, et al. Redox-mediated reciprocal regulation of SERCA and Na+-Ca2+ exchanger contributes to sarcoplasmic reticulum Ca2+ depletion in cardiac myocytes. Free Radic Biol Med. 2010;48(9):1182\u20137.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"1984_CR33","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cardiores.2006.02.019","volume":"71","author":"AV Zima","year":"2006","unstructured":"Zima AV, Blatter LA. Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res. 2006;71(2):310\u201321.","journal-title":"Cardiovasc Res"},{"issue":"39","key":"1984_CR34","doi-asserted-by":"crossref","first-page":"14104","DOI":"10.1073\/pnas.0504298102","volume":"102","author":"Z Kubalova","year":"2005","unstructured":"Kubalova Z, Terentyev D, Viatchenko-Karpinski S, Nishijima Y, Gyorke I, Terentyeva R, et al. Abnormal intrastore calcium signaling in chronic heart failure. Proc Natl Acad Sci U S A. 2005;102(39):14104\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"1984_CR35","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.3390\/ijms19082234","volume":"19","author":"PG Vikhorev","year":"2018","unstructured":"Vikhorev PG, Vikhoreva NN. Cardiomyopathies and related changes in contractility of human heart muscle. Int J Mol Sci. 2018;19(8):2234.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1984_CR36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.stemcr.2014.06.003","volume":"3","author":"CI Spencer","year":"2014","unstructured":"Spencer CI, Baba S, Nakamura K, Hua EA, Sears MA, Fu CC, et al. Calcium transients closely reflect prolonged action potentials in iPSC models of inherited cardiac arrhythmia. Stem Cell Rep. 2014;3(2):269\u201381.","journal-title":"Stem Cell Rep"},{"key":"1984_CR37","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/978-94-017-9211-0_18","volume":"85","author":"AV Budanov","year":"2014","unstructured":"Budanov AV. The role of tumor suppressor p53 in the antioxidant defense and metabolism. Subcell Biochem. 2014;85:337\u201358.","journal-title":"Subcell Biochem"},{"issue":"17","key":"1984_CR38","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1158\/0008-5472.CAN-04-0494","volume":"64","author":"G Achanta","year":"2004","unstructured":"Achanta G, Huang P. Role of p53 in sensing oxidative DNA damage in response to reactive oxygen species-generating agents. Cancer Res. 2004;64(17):6233\u20139.","journal-title":"Cancer Res"},{"key":"1984_CR39","doi-asserted-by":"crossref","unstructured":"Sala V, Della Sala A, Hirsch E, Ghigo A. Signaling pathways underlying anthracycline cardiotoxicity. Antioxid Redox Signal. 2020;32(15):1098\u2013114.","DOI":"10.1089\/ars.2020.8019"},{"issue":"6","key":"1984_CR40","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.molcel.2009.04.029","volume":"34","author":"W Chen","year":"2009","unstructured":"Chen W, Sun Z, Wang XJ, Jiang T, Huang Z, Fang D, et al. Direct interaction between Nrf2 and p21(Cip1\/WAF1) upregulates the Nrf2-mediated antioxidant response. Mol Cell. 2009;34(6):663\u201373.","journal-title":"Mol Cell"},{"issue":"22","key":"1984_CR41","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1242\/dev.030338","volume":"136","author":"A Moustakas","year":"2009","unstructured":"Moustakas A, Heldin CH. The regulation of TGF-beta signal transduction. Development. 2009;136(22):3699\u2013714.","journal-title":"Development."},{"key":"1984_CR42","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fcvm.2019.00140","volume":"6","author":"A Hanna","year":"2019","unstructured":"Hanna A, Frangogiannis NG. The role of the TGF-beta superfamily in myocardial infarction. Front Cardiovasc Med. 2019;6:140.","journal-title":"Front Cardiovasc Med"},{"key":"1984_CR43","doi-asserted-by":"crossref","first-page":"101432","DOI":"10.1016\/j.redox.2020.101432","volume":"30","author":"X Yang","year":"2020","unstructured":"Yang X, An N, Zhong C, Guan M, Jiang Y, Li X, et al. Enhanced cardiomyocyte reactive oxygen species signaling promotes ibrutinib-induced atrial fibrillation. Redox Biol. 2020;30:101432.","journal-title":"Redox Biol"},{"key":"1984_CR44","first-page":"619185","volume":"2012","author":"OA Al-Shabanah","year":"2012","unstructured":"Al-Shabanah OA, Aleisa AM, Hafez MM, Al-Rejaie SS, Al-Yahya AA, Bakheet SA, et al. Desferrioxamine attenuates doxorubicin-induced acute cardiotoxicity through TGF-beta\/Smad p53 pathway in rat model. Oxidative Med Cell Longev. 2012;2012:619185.","journal-title":"Oxidative Med Cell Longev"},{"key":"1984_CR45","doi-asserted-by":"crossref","first-page":"490842","DOI":"10.1155\/2015\/490842","volume":"2015","author":"R Adela","year":"2015","unstructured":"Adela R, Banerjee SK. GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective. J Diabetes Res. 2015;2015:490842.","journal-title":"J Diabetes Res"},{"issue":"1","key":"1984_CR46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1073\/pnas.97.1.109","volume":"97","author":"M Tan","year":"2000","unstructured":"Tan M, Wang Y, Guan K, Sun Y. PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway. Proc Natl Acad Sci U S A. 2000;97(1):109\u201314.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1984_CR47","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cardiores.2006.10.002","volume":"74","author":"M Bujak","year":"2007","unstructured":"Bujak M, Frangogiannis NG. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res. 2007;74(2):184\u201395.","journal-title":"Cardiovasc Res"},{"key":"1984_CR48","doi-asserted-by":"crossref","first-page":"44735","DOI":"10.1038\/srep44735","volume":"7","author":"L Zhao","year":"2017","unstructured":"Zhao L, Zhang B. Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes. Sci Rep. 2017;7:44735.","journal-title":"Sci Rep"},{"issue":"13","key":"1984_CR49","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.celrep.2018.08.079","volume":"24","author":"K Blinova","year":"2018","unstructured":"Blinova K, Dang Q, Millard D, Smith G, Pierson J, Guo L, et al. International multisite study of human-induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment. Cell Rep. 2018;24(13):3582\u201392.","journal-title":"Cell Rep"},{"key":"1984_CR50","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fphys.2018.00080","volume":"9","author":"JT Koivumaki","year":"2018","unstructured":"Koivumaki JT, Naumenko N, Tuomainen T, Takalo J, Oksanen M, Puttonen KA, et al. Structural immaturity of human iPSC-derived cardiomyocytes: in silico investigation of effects on function and disease modeling. Front Physiol. 2018;9:80.","journal-title":"Front Physiol"},{"key":"1984_CR51","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.freeradbiomed.2015.11.013","volume":"90","author":"R Ni","year":"2016","unstructured":"Ni R, Cao T, Xiong S, Ma J, Fan GC, Lacefield JC, et al. Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy. Free Radic Biol Med. 2016;90:12\u201323.","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"1984_CR52","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/cvr\/cvz023","volume":"115","author":"I Raber","year":"2019","unstructured":"Raber I, Asnani A. Cardioprotection in cancer therapy: novel insights with anthracyclines. Cardiovasc Res. 2019;115(5):915\u201321.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"1984_CR53","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s000180300001","volume":"60","author":"M Zafarullah","year":"2003","unstructured":"Zafarullah M, Li WQ, Sylvester J, Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci. 2003;60(1):6\u201320.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"1984_CR54","first-page":"11","volume":"19","author":"V Mokhtari","year":"2017","unstructured":"Mokhtari V, Afsharian P, Shahhoseini M, Kalantar SM, Moini A. A review on various uses of N-acetyl cysteine. Cell J. 2017;19(1):11\u20137.","journal-title":"Cell J"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01984-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-020-01984-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01984-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T06:15:23Z","timestamp":1604556923000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-020-01984-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1984"],"URL":"https:\/\/doi.org\/10.1186\/s13287-020-01984-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-45895\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-45895\/v1","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,5]]},"assertion":[{"value":"19 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"470"}}